To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia

NCT03413384 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease Dementia

Interventions

DRUG: Ceftriaxone
OTHER: Placebo

Sponsor

BrainX Corporation

Collaborators

[object Object]